4
Changes in Ownership
Ovid Therapeutics Inc. Filed Acc 0001779359-26-000004
Chief Financial Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Carter Charles Ross Chief Financial Officer | 2026-07-06 | Grant or award | +50,000 | 94,375 | D |
Loading xslF345X06/form4-07082026_080741.xml…